News & Perspective

Oct 31, 2008

Oct 31, 2008

Encouraging results reported for injectable flu drug

(CIDRAP News) – BioCryst Pharmaceuticals Inc. reported encouraging results this week in two phase 2 trials of its injectable antiviral drug, peramivir, a potential new treatment for influenza.

Peramivir is a neuraminidase inhibitor, like the licensed antivirals oseltamivir (Tamiflu), which is taken orally, and zanamivir (Relenza), inhaled as a powder.

Jun 06, 2006

Jun 06, 2006

WHO confirms Indonesian H5N1 case; nurses test negative

(CIDRAP News) – The World Health Organization (WHO) today confirmed that a 15-year-old Indonesian boy who died May 30 had H5N1 avian influenza, but the agency said four nurses who had suspicious symptoms after caring for avian flu patients were not infected.